IUGNF
PINK Imugene Ltd$0.0579 ↑ +0.0207 (+55.65%) Trading Up from the previous close of $0.0372, and at the day’s high of $0.0579
- YTD change
- -77.73%
- vs 20-day SMA
- +60.18%
- vs 200-day SMA
- -61.25%
Price ranges
Price & Performance
-0.05 (-45.89%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 81.3% away from all-time highs of $0.3101
- IUGNF is down 78% since the beginning of the year
- IUGNF is down 78% over the past 12 months
- IUGNF is down 3% over the past 1 month
IUGNF reads n/a: price sits above one of the two key moving averages, the 12-month move is -75.3%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0190
- Last 5 days
- +33.87%
- vs 8-day SMA
- +118.04%
No alerts for IUGNF in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.